$8.06
-0.15-1.83%
Pre-Market: 6:54 AM EDT
Comments
Loading...
Latest Zevra Therapeutics Stock News | NASDAQ:ZVRA | Benzinga
Get the latest news on Zevra Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Zevra Therapeutics performance
Categories: All
Thursday, March 13, 2025
Wednesday, March 12, 2025
Tuesday, March 11, 2025
Thursday, February 27, 2025
Tuesday, December 17, 2024
Thursday, November 21, 2024
Wednesday, November 20, 2024
Thursday, November 14, 2024
Tuesday, November 12, 2024
Monday, November 11, 2024
Friday, October 11, 2024
Wednesday, October 09, 2024
Monday, October 07, 2024
Tuesday, October 01, 2024
Monday, September 30, 2024
Tuesday, September 24, 2024
- Beyond The Numbers: 7 Analysts Discuss Zevra Therapeutics Stock
- Zevra Therapeutics shares are trading higher ...
- JMP Securities Initiates Coverage On Zevra Th...
- Maxim Group Maintains Buy on Zevra Therapeuti...
- Roth MKM Maintains Buy on Zevra Therapeutics,...
- Zevra Therapeutics Says It Will Present Top-L...
Monday, September 23, 2024
Friday, September 20, 2024
Wednesday, September 18, 2024
Friday, September 06, 2024
Monday, August 19, 2024
Thursday, August 15, 2024
Wednesday, August 14, 2024
Tuesday, August 13, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Monday, August 05, 2024
- Cantor Fitzgerald Reiterates Overweight on Ze...
- Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases